Calidi Biotherapeutics Inc (CLDI)
Calidi Biotherapeutics - Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study
Calidi Biotherapeutics - Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study
Inspire Medical Systems, Inc. - Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy’s for XACDURO® in Select International Markets
Global Credit Union selects NCR Atleos ATMs to support new Utqiaġvik branch in Alaska’s northernmost city
BARK and Guy Fieri Are Taking Dogs Straight to Flavortown
Pennymac Names AWS as Preferred Cloud Provider, Expanding Strategic Agreement to Deploy Enterprise-Grade AI and Commercialize its Servicing Platform
Real’s Monthly Agent Survey: Buyers Pull Back Amid Economic Uncertainty, While Sellers Reset Expectations
Abrams Capital Disposes of Shares of SECURE Waste Infrastructure Corp.
JLens Urges Cloudflare Shareholders to Vote WITHHOLD on the Election of Two Directors at the Annual Meeting on June 30, 2026